Sofinnova Investments, Inc.

Q4 2018 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park, CA
Holdings as of
December 31, 2018
Value $
$803M
Num holdings
59
Date filed
2/22/2019, 12:07 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q3 2018 - Nov 15, 2018
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2018 Q4 - Restatement compared to 2018 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 2/21/2019

This Amendment No. 1 is being filed to report the holdings of Nucana plc (f/k/a Nucana Biomed Ltd) in a manner consistent with the Reporting Manager's previous Form 13F filing. For the avoidance of doubt, the Reporting Manager did not dispose of such securities between the filing of the previous Form 13F and this Amendment No. 1.Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VII, L.L.C., Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., and Sofinnova BioEquities GP LLC.

Other Included Managers (2):

Num Name Location File Number
1 Crestline Management, LP 028-14917
2 Blackstone Alternative Asset Management L.P.